Green Thumb: Analyst Consensus Estimates For Q3 2021

Green Thumb Industries (CSE: GTII) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus C$59.06 12-month price target on the company, via a total of 16 analysts, with 4 analysts having strong buy ratings, and the other 12 having buy ratings on the company. The street high comes from Stifel-GMP with an C$80 price target, and the lowest target comes from Roth Capital Partners with a C$40 price target.

15 analysts have revenue estimates for the third quarter. The mean between all 15 is US$233.33 million; this number has been revised slightly upwards from US$221.54 million at the start of May. The street high is US$250.60 million while the lowest sits at US$222.27 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.32%, with this number being flat at the start of May. Street high is 57% estimate and the lowest sits at 54%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$82.54 million, with this number being basically flat since the start of May. Street high sits at US$88.70 million EBITDA and the lowest being a US$78.23 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Gold & Silver Just Added $2 Billion to This Project | Aya Gold – Bourmadine PEA

Recommended

Japan Gold Lands $50 Million in Committed Capital Through Solidcore Alliance

Blue Jay Gold Produces 66.9% Antimony Concentrate at 93.9% Recovery From Becker-Cochran

Related News

Harvest Health: Canaccord, Stifel Raise Price Targets

Earlier this week, Harvest Health & Recreation (CSE: HARV) released its third quarter results. The...

Thursday, November 12, 2020, 03:57:03 PM

Else Nutrition: Canaccord Drops Price Target To $5.75

On Friday, Else Nutrition (CSE: BABY) reported their fourth quarter and year end financials. The...

Monday, May 3, 2021, 11:44:00 AM

US Cannabis: Illustrating The Performance Of The Top Four Issuers

The upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which...

Monday, October 26, 2020, 12:30:00 PM

Cresco Labs: Cantor Lowers Price Target To $12.65

On September 3, Cresco Labs (CSE: CL) announced that they closed their acquisition of Cultivate,...

Thursday, September 16, 2021, 03:37:00 PM

Harvest Health: Canaccord Reiterates Price Target Following Earnings

On August 10, Harvest Health and Recreation (CSE: HARV) reported its second quarter results. The...

Thursday, August 12, 2021, 03:49:00 PM